2874 related articles for article (PubMed ID: 11559546)
41. Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily.
Remacle-Bonnet M; Garrouste F; Baillat G; Andre F; Marvaldi J; Pommier G
Am J Pathol; 2005 Sep; 167(3):761-73. PubMed ID: 16127155
[TBL] [Abstract][Full Text] [Related]
42. PKCdelta and mTOR interact to regulate stress and IGF-I induced IRS-1 Ser312 phosphorylation in breast cancer cells.
Mingo-Sion AM; Ferguson HA; Koller E; Reyland ME; Van Den Berg CL
Breast Cancer Res Treat; 2005 Jun; 91(3):259-69. PubMed ID: 15952059
[TBL] [Abstract][Full Text] [Related]
43. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
[TBL] [Abstract][Full Text] [Related]
44. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
Stoica GE; Franke TF; Moroni M; Mueller S; Morgan E; Iann MC; Winder AD; Reiter R; Wellstein A; Martin MB; Stoica A
Oncogene; 2003 Sep; 22(39):7998-8011. PubMed ID: 12970748
[TBL] [Abstract][Full Text] [Related]
45. Parallel phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways subserve the mitogenic and antiapoptotic actions of insulin-like growth factor I in osteoblastic cells.
Grey A; Chen Q; Xu X; Callon K; Cornish J
Endocrinology; 2003 Nov; 144(11):4886-93. PubMed ID: 12960100
[TBL] [Abstract][Full Text] [Related]
46. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
47. Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancer.
Lee CT; Park KH; Adachi Y; Seol JY; Yoo CG; Kim YW; Han SK; Shim YS; Coffee K; Dikov MM; Carbone DP
Cancer Gene Ther; 2003 Jan; 10(1):57-63. PubMed ID: 12489029
[TBL] [Abstract][Full Text] [Related]
48. Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis.
Eckert LB; Repasky GA; Ulkü AS; McFall A; Zhou H; Sartor CI; Der CJ
Cancer Res; 2004 Jul; 64(13):4585-92. PubMed ID: 15231670
[TBL] [Abstract][Full Text] [Related]
49. Synergistic proliferative action of insulin-like growth factor I and 17 beta-estradiol in MCF-7S breast tumor cells.
Hamelers IH; van Schaik RF; van Teeffelen HA; Sussenbach JS; Steenbergh PH
Exp Cell Res; 2002 Feb; 273(1):107-17. PubMed ID: 11795951
[TBL] [Abstract][Full Text] [Related]
50. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
[TBL] [Abstract][Full Text] [Related]
51. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway.
Kurihara S; Hakuno F; Takahashi S
Endocr J; 2000 Dec; 47(6):739-51. PubMed ID: 11228049
[TBL] [Abstract][Full Text] [Related]
52. Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis.
Scrimgeour AG; Blakesley VA; Stannard BS; LeRoith D
Endocrinology; 1997 Jun; 138(6):2552-8. PubMed ID: 9165048
[TBL] [Abstract][Full Text] [Related]
53. The role of growth factor receptor pathways in human breast cancer cells adapted to long-term estrogen deprivation.
Sabnis GJ; Jelovac D; Long B; Brodie A
Cancer Res; 2005 May; 65(9):3903-10. PubMed ID: 15867390
[TBL] [Abstract][Full Text] [Related]
54. Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells.
Márquez DC; Pietras RJ
Oncogene; 2001 Sep; 20(39):5420-30. PubMed ID: 11571639
[TBL] [Abstract][Full Text] [Related]
55. The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner.
Chakravarti A; Chakladar A; Delaney MA; Latham DE; Loeffler JS
Cancer Res; 2002 Aug; 62(15):4307-15. PubMed ID: 12154034
[TBL] [Abstract][Full Text] [Related]
56. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
[TBL] [Abstract][Full Text] [Related]
57. Sustained Akt/PKB activation and transient attenuation of c-jun N-terminal kinase in the inhibition of apoptosis by IGF-1 in vascular smooth muscle cells.
Allen RT; Krueger KD; Dhume A; Agrawal DK
Apoptosis; 2005 May; 10(3):525-35. PubMed ID: 15909115
[TBL] [Abstract][Full Text] [Related]
58. Genetic blockade of the insulin-like growth factor-I receptor: a promising strategy for human pancreatic cancer.
Min Y; Adachi Y; Yamamoto H; Ito H; Itoh F; Lee CT; Nadaf S; Carbone DP; Imai K
Cancer Res; 2003 Oct; 63(19):6432-41. PubMed ID: 14559833
[TBL] [Abstract][Full Text] [Related]
59. Insulin-like growth factor-1 (IGF-1) induces the activation/phosphorylation of Akt kinase and cAMP response element-binding protein (CREB) by activating different signaling pathways in PC12 cells.
Zheng WH; Quirion R
BMC Neurosci; 2006 Jun; 7():51. PubMed ID: 16792806
[TBL] [Abstract][Full Text] [Related]
60. HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells.
Knuefermann C; Lu Y; Liu B; Jin W; Liang K; Wu L; Schmidt M; Mills GB; Mendelsohn J; Fan Z
Oncogene; 2003 May; 22(21):3205-12. PubMed ID: 12761490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]